Discover
CORT
Corcept Therapeutics Incorporated
93.77
1 x 93.68
1 x 93.86
bid
ask
-
1.88
1.96%
12:03 PM
timesize
| Ytd | 169.46% | |
| 1y | 35.74% |
92.90
day range
95.65
28.66
52 week range
95.79
| Open | 95.18 | Prev Close | 95.65 | Low | 92.90 | High | 95.65 | Mkt Cap | 10.27B |
| Vol | 165.17K | Avg Vol | 1.12M | EPS | 0.35 | P/E | 273.29 | Forward P/E | 111.11 |
| Beta | 0.47 | Short Ratio | 8.57 | Inst. Own | 75.56% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 76.66 | 200-d Avg | 61.22 | 1yr Est | 106.00 |
| Income Statement | |||
| Total Revenue | 164.90M | ||
| Revenues (USD) | 164.90M | ||
| Cost of Revenue | 2.88M | ||
| Gross Profit | 162.02M | ||
| Operating Expenses | 211.62M | ||
| Research and Development Expense | 66.27M | ||
| Selling, General and Administrative Expense | 145.36M | ||
| Operating Income | -49.60M | ||
| Interest Expense | -4.89M | ||
| Income Tax Expense | -12.95M | ||
| Net Income | -31.20M | ||
| Net Income Common Stock | -31.20M | ||
| Net Income Common Stock (USD) | -31.20M | ||
| Consolidated Income | -31.76M | ||
| Net Income to Non-Controlling Interests | -559.00K | ||
| Earnings per Basic Share | -0.30 | ||
| Earnings per Basic Share (USD) | -0.30 | ||
| Earnings per Diluted Share | -0.30 | ||
| Earning Before Interest & Taxes (EBIT) | -49.04M | ||
| Earning Before Interest & Taxes (USD) | -49.04M | ||
| Weighted Average Shares | 104.44M | ||
| Weighted Average Shares Diluted | 104.44M | ||
| Balance Sheet | |||
| Cash and Equivalents | 108.74M | ||
| Cash and Equivalents (USD) | 108.74M | ||
| Investments | 406.71M | ||
| Investments Current | 229.45M | ||
| Investments Non-Current | 177.26M | ||
| Trade and Non-Trade Receivables | 39.07M | ||
| Current Assets | 426.03M | ||
| Property, Plant & Equipment Net | 10.37M | ||
| Total Assets | 814.88M | ||
| Debt Current | 1.63M | ||
| Total Debt | 9.64M | ||
| Current Liabilities | 149.19M | ||
| Debt Non-Current | 8.01M | ||
| Total Liabilities | 176.89M | ||
| Accumulated Retained Earnings (Deficit) | 611.63M | ||
| Accumulated Other Comprehensive Income | 918.00K | ||
| Shareholders Equity | 637.99M | ||
| Shareholders Equity (USD) | 637.99M | ||
| Assets Non-Current | 388.85M | ||
| Total Debt (USD) | 9.64M | ||
| Inventory | 27.40M | ||
| Liabilities Non-Current | 27.71M | ||
| Trade and Non-Trade Payables | 33.31M | ||
| Tax Assets | 181.56M | ||
| Tax Liabilities | 15.33M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 598.00K | ||
| Net Cash Flow from Financing | 760.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -11.76M | ||
| Capital Expenditure | -201.00K | ||
| Issuance (Purchase) of Equity Shares | 760.00K | ||
| Net Cash Flow from Investing | 4.54M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 4.74M | ||
| Net Cash Flow from Operations | -16.77M | ||
| Effect of Exchange Rate Changes on Cash | -287.00K | ||
| Share Based Compensation | 23.04M | ||